题名

成人期體重增加與代謝症候群之相關性

并列篇名

Association of Weight Gain in Adulthood and Metabolic Syndrome

作者

洪瑞麟(Rui-Lin Hong);黃偉新(Wei-Hsin Huang);詹欣隆(Hsin-Lung Chan);黃麗卿(Lee-Ching Hwang)

关键词

weight gain ; metabolic syndrome ; cardiovascular diseases

期刊名称

台灣家庭醫學雜誌

卷期/出版年月

23卷2期(2013 / 06 / 01)

页次

83 - 92

内容语文

繁體中文

中文摘要

背景及目的:肥胖與高血壓、心血管疾病、代謝症候群、糖尿病及血脂肪異常等慢性疾病的發生關係密切,本研究目的在探討成人期體重增加對代謝症候群及心血管疾病的危險因子的關連性。方法:收集30歲以上體重過重的331位員工參與本研究,以問卷登錄個案基本資料,包括個人疾病史,個人生活習慣史及成人初期(20歲)體重,並測量身高、體重、腰圍與血壓,血液檢查包含空腹血糖值、總膽固醇、三酸甘油酯、高密度脂蛋白膽固醇與空腹血清胰島素值。成人期體重增加定義為測量體重減成人初期體重。結果:趨勢檢定分析顯示成人期體重增加組別越高與代謝症候群及各心血管疾病危險因子上升有統計上顯著相關。使用偏相關分析,控制年齡,性別影響後,發現成人期體重增加與各種肥胖指標(身體質量指數,腰圍,體脂肪百分比)和血壓呈現顯著的相關性,並與胰島素阻抗呈現正相關性;多變項分析結果顯示即使控制成人初期體重,成人期間體重每增加一公斤,得到代謝症候群的風險增加15%,胰島素阻抗的風險增加13%。結論:成人期體重增加和肥胖指標及各種代謝危險因子呈現正相關性,可能罹患代謝症候群和心血管疾病風險增加,此結果提供衛生政策應加強民眾在成人期初期時應重視體重管理的證據,以期達到預防勝於治療的目標。

英文摘要

Background: Obesity is closely related to chronic diseases such as hypertension, cardiovascular diseases, metabolic syndrome, diabetes mellitus, and dyslipidemia. This study discussed the relationship between cardiovascular risk factors with adult weight gain and metabolic syndrome.Methods: There were 331 overweight employees over 30 years of age who were recruited into the study. Each subject profile was obtained via questionnaires, consisting of questions related to personal medical history, dietary habits and early adult weight (at 20 years of age). Weight gain in adulthood was defined as the difference between measured weight and weight in early adulthood.Results: According to the trend test analysis, weight gain in adulthood is significantly related to both metabolic syndrome and cardiovascular disease. After applying Pearson's correlation coefficient and adjustments for age and sex, the results revealed that weight gain in adulthood was significantly related to body mass index, abdominal circumference, percentage of body fat and insulin resistance. Multivariate analysis showed that even with well-controlled early adulthood weight, the risk of acquiring metabolic syndrome and insulin resistance increased significantly.Conclusion: Weight gain in adulthood positively correlated with multiple metabolic risk factors, possibly resulting in increased risks of acquiring metabolic syndrome and cardiovascular disease. This study pointed out the importance of weight management in early adulthood and serves as evidence for preventive medicine-focused health policies.

主题分类 醫藥衛生 > 社會醫學
参考文献
  1. Alley, DE,Chang, VW(2010).Metabolic syndrome and weight gain in adulthood.J Gerontol A Biol Sci Med Sci,65,111-7.
  2. American Diabetes Association(2006).Diagnosis and classification of diabetes mellitus.Diabetes Care,29,S43-S48.
  3. Anderson, JW,Konz, EC(2001).Obesity and disease management: effects of weight loss on comorbid conditions.Obes Res,9(Suppl 4),326S-4S.
  4. Bot, M,Spijkerman, AM,Twisk, JW,Verschuren, WM(2010).Weight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohort.Eur J Epidemiol,25,125-33.
  5. Bowman TS, Kurth T, Sesso HD, Manson JE, Gaziano JM(2007).Eight-year change in body mass index and subsequent risk of cardiovascular disease among healthy non-smoking men.Prev Med,45,436-41.
  6. Chou, WT,Kakizaki, M,Tomata, Y(2013).Impact of weight change since age 20 and cardiovascular disease mortality risk.Circ J,77,679-86.
  7. Després, JP,Lemieux, I,Bergeron, J(2008).Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.Arterioscler Thromb Vasc Biol,28,1039-49.
  8. Diaz, VA,Mainous, AG,Everett, CJ(2005).The association between weight fluctuation and mortality: results from a population-based cohort study.J Community Health,30,153-65.
  9. Everson, SA,Goldberg, DE,Helmrich, SP(1998).Weight gain and the risk of developing insulin resistance syndrome.Diabetes Care,21,1637-43.
  10. Expert Panel on Detection, Evaluation,Treatment of High Blood Cholesterol in Adults(2001).Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).JAMA,285,2486-97.
  11. Fain, JN(2011).Correlative studies on the effects of obesity, diabetes and hypertension on gene expression in omental adipose tissue of obese women.Nutr Diabetes,1,e17.
  12. Foreyt, JP(2005).Need for lifestyle intervention: how to begin.Am J Cardiol,96,11-4.
  13. Grundy, SM,Hansen, B,Smith, SC,Cleeman, JI,Kahn, RA(2004).Clinical management of metabolic syndrome.Circulation,109,551-6.
  14. Hankey, GJ,Jamrozik, K,Broadhurst, RJ(1998).Long-term risk of first recurrent stroke in the Perth Community Stroke Study.Stroke,29,2491-500.
  15. Harris, TB,Savage, PJ,Tell, GS,Haan, M,Kumanyika, S,Lynch, JC(1997).Carrying the burden of cardiovascular risk in old age: associations of weight and weight change with prevalent cardiovascular disease, risk factors, and health status in the Cardiovascular Health Study.Am J Clin Nutr,66,837-44.
  16. Hillier, TA,Fagot-Campagna, A,Eschwège, E(2006).Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the D.E.S.I.R. cohort.Int J Epidemiol,35,190-6.
  17. Hotamisligil, GS,Arner, P,Caro, JF,Atkinson, RL,Spiegelman, BM(1995).Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.J Clin Invest,95,2409-15.
  18. Huang, Z,Willett, WC,Manson, JE(1998).Body weight, weight change, and risk for hypertension in women.Arch Intern Med,128,81-8.
  19. Landsberg, L(2005).Insulin resistance and the metabolic syndrome.Diabetologia,48,1244-6.
  20. Lin, LY,Kuo, HK,Li, HY,Hwang, JJ,Lin, JW(2008).Confirming a biological pathway in the metabolic syndrome-insight from the NHANES 1999-2002.Obesity,16,2676-81.
  21. Malmberg, K,Ryden, L,Wedel, H(2005).Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.Eur Heart J,26,650-61.
  22. Matthews, DR,Hosker, JP,Rudenski, AS,Naylor, BA,Treacher, DF,Turner, RC(1985).Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia,28,412-9.
  23. McAdams, MA,Van Dam, RM,Hu, FB(2007).Comparison of self-reported and measured BMI as correlates of disease markers in US adults.Obesity,15,188-96.
  24. Mohamed-Ali, V,Goodrick, S,Rawesh, A(1997).Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.J Clin Endocrinol Metab,82,4196-200.
  25. Poirier, P,Giles, TD,Bray, GA(2006).Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight Loss. An update of the 1997 American heart association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism.Circulation,113,898-918.
  26. Pyorala, M,Miettinen, H,Halonen, P,Laakso, M,Pyorala, K(2000).Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study.Arterioscler Thromb Vasc Biol,20,538-44.
  27. Silvestri, A,Gebara, O,Vitale, C(2003).Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.Circulation,107,3165-9.
  28. Trevisan, M,Liu, J,Bahsas, FB,Menotti, A(1998).Syndrome X and mortality: a populationbased study. Risk Factor and Life Expectancy Research Group.Am J Epidemiol,148,958-66.
  29. Truesdale, KP,Stevens, J,Lewis, CE,Schreiner, PJ,Loria, CM,Cai, J(2006).Changes in risk factors for cardiovascular disease by baseline weight status in young adults who maintain or gain weight over 15 years: the CARDIA study.Int J Obes,30,1397-407.
  30. Wannamethee, SG,Shaper, AG,Walker, M(2005).Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes.J Epidemiol Community Health,59,134-9.
  31. Wilson, PW,Kannel, WB,Silbershatz, H,D'Agostino, RB(1999).Clustering of metabolic factors and coronary heart disease.Arch Intern Med,159,1104-9.
  32. World Health Organization(1999).consultationconsultation,Geneva, Switzerland:World Health Organization.
  33. 葉志嶸、張新儀、潘文涵(2005)。台灣營養健康調查台灣營養健康調查,未出版
被引用次数
  1. 許中華,林英,林佳,李梅琛,吳淑芳(2019)。代謝症候群患者與中醫證型之差異分析。中醫內科醫學雜誌,17(1),13-29。